Sex differences in psychiatric symptoms among methamphetamine-dependent residents in sober living houses

Addictive Disorders and their Treatment

Volumn 11, Issue 2, 2012, Pages 53-63

  Polcin, Douglas Lawrence ^a   Buscemi, Raymond ^b   Nayak, Madhabika ^a   Korcha, Rachael ^a   Galloway, Gantt Perkins ^c  

^a PUBLIC HEALTH INSTITUTE   (United States)

^b Private Practice ^*  (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

comorbidity; methamphetamine; psychiatric symptoms; sex differences; sober living houses

Indexed keywords

ADULT; AGORAPHOBIA; ARTICLE; BULIMIA; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DEPENDENCE TREATMENT; FEMALE; GENERALIZED ANXIETY DISORDER; HEALTH CARE FACILITY; HUMAN; HYPOCHONDRIASIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; METHAMPHETAMINE DEPENDENCE; OBSESSIVE COMPULSIVE DISORDER; PANIC; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOSIS; SEX DIFFERENCE; SOBER LIVING HOUSE; SOCIAL PHOBIA; SOMATIZATION;

EID: 84861230083     PISSN: 15315754     EISSN: None     Source Type: Journal    
DOI: 10.1097/ADT.0b013e3182213ef1     Document Type: Article

References (39)

1. Substance Abuse and Mental Health Services Administration. National Survery on Drug Use and Health. December 30, 2008; Available from: http://www.oas.samhsa.gov/methTabs.htm.
2. Nicosia N, Pacula RL, Beau K, et al. The Economic Cost of Methamphetamine Use in the United States. Santa Monica: RAND Corp; 2005.
3. London JA, Utter GH, Battistella F, et al. Methamphetamine use is associated with increased hospital resource consumption among minimally injured trauma patients. J Trauma. 2009;66: 485-490.
4. Swanson SM, Sise CB, Sise MJ, et al. The scourge of methamphetamine: impact on a level I trauma center. J Trauma. 2007;63: 531-537.
5. Yegiyants S, Abraham J, Taylor E. The effects of methamphetamine use on trauma patient outcome. Am Surg. 2007;73: 1044-1046. (Pubitemid 351396564)
6. Mitka M. Meth lab fires put heat on burn centers. JAMA. 2005;294: 2009-2010. (Pubitemid 41539928)
7. Curtis EK. Meth mouth: a review of methamphetamine abuse and its oral manifestations. Gen Dent. 2006;54: 125-129. (Pubitemid 43672280)
8. Department of Justice, U.S.D.E.A. National Drug Threat Assessment 2008. 2008; Available from: http://www.usdoj.gov/ndic/pubs25/25921/index.htm.
9. Anglin MD, Urada D, Brecht M. Criminal justice treatment admissions for methamphetamine use in California: a focus on Proposition 36. J Psychoactive Drugs. 2007;(suppl 4): 367-381.
10. Iritani BJ, Hallfors DD, Bauer DJ. Crystal methamphetamine use among young adults in the USA. Addiction. 2007;102: 1102-1113. (Pubitemid 46918668)
11. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, et al. Clinical course and outcomes of methamphetamine- dependent adults with psychosis. J Subst Abuse Treat. 2008;35: 445-450.
12. Hillhouse MP, Marinelli-Casey P, Gonzales R, et al. Predicting in-treatment performance and post-treatment outcomes in methamphetamine users. Addiction. 2007;102(suppl 1): 84-95. (Pubitemid 46328206)
13. Hser YI, Evans E, Huang YC. Treatment outcomes among women and men methamphetamine abusers in California. J Subst Abuse Treat. 2005; 28: 77-85. (Pubitemid 40250486)
14. Petry NM. A comprehensive guide to the application of contingency management procedures in clinical settings. Drug Alcohol Depend. 2000;58: 9-25.
15. Stalcup SA, Christian D, Stalcup J, et al. A treatment model for craving identification and management. J Psychoactive Drugs. 2006;38: 189-202. (Pubitemid 44141298)
16. Carroll KM, Ball SA, Nich C, et al. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Depend. 2006;81: 301-312. (Pubitemid 43152457)
17. Polcin DL, Henderson D. A clean and sober place to live: philosophy, structure, and purported therapeutic factors in sober living houses. J Psychoactive Drugs. 2008;40: 153-159.
18. Brecht ML, O'Brien A, Von Mayrhauser C, et al. Methamphetamine use behaviors and gender differences. Addict Behav. 2004;29: 89-106. (Pubitemid 37518229)
19. Cohen JB, Greenberg S, Uri J, et al. Women with methamphetamine dependence: research on etiology and treatment. J Psychoactive Drugs. 2007; (suppl 4): 347-351.
20. Dluzen DE, Liu B. Gender differences in methamphetamine use and responses: a review. Gend Med. 2008;5: 24-35. (Pubitemid 351506544)
21. Strauss S, Falkin G. Women offenders who use and deal methamphetamine: Implications for mandated drug treatment. Women Crim Just. 2001;12: 77-97.
22. Semple SJ, Zians J, Strathdee SA, et al. Psychosocial and behavioral correlates of depressed mood among female methamphetamine users. J Psychoactive Drugs. 2007;(suppl 4): 353-366.
23. Maglione M, Chao B, Anglin D. Correlates of outpatient drug treatment drop-out among methamphetamine users. J Psychoactive Drugs. 2000;32: 221-228.
24. Fiorentine R, Anglin D, Gil-Rivas V, et al. Drug treatment: explaining the gender paradox. Subst Use Misuse. 1997;32: 653-678. (Pubitemid 27240624)
25. Gil-Rivas V, Fiorentine R, Anglin D. Sexual abuse, physical abuse, and posttraumatic stress disorder among women participating in outpatient drug abuse treatment. J Psychoactive Drugs. 1996;28: 95-102. (Pubitemid 26112112)
26. Zweben JE, Cohen JB, Christian D, et al. Psychiatric symptoms in methamphetamine users. Am J Addict. 2004;13: 181-190. (Pubitemid 38585698)
27. Sonne SC, Back SE, Zuniga CD, et al. Gender differences in individuals with comorbid alcohol dependence and post-traumatic stress disorder. Am J Addict. 2003;12: 412-423. (Pubitemid 37449027)
28. Barr AM, Panenka WJ, MacEwan GW, et al. The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci. 2006;31: 301-313. (Pubitemid 44497427)
29. Christian DR, Huber A, Brecht ML, et al. Methamphetamine users entering treatment: characteristics of the methamphetamine treatment project sample. Subst Use Misuse. 2007;42: 2207-2222.
30. Flaum M, Schultz S. When does amphetamineinduced psychosis become schizophrenia? Am J Psychiatry. 1996;153: 812-815. (Pubitemid 26170544)
31. Yui K, Ikemoto S, Ishiguro T, et al. Susceptibility to subsequent episodes in spontaneous recurrence of methamphetamine psychosis. Ann N Y Acad Sci. 2000;914: 292-302.
32. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61: 807-816. (Pubitemid 39031120)
33. Compton WM III, Cottler LB, Abdallah AB, et al. Substance dependence and other psychiatric disorders among drug dependent subjects: race and gender correlates. Am J Addict. 2000;9: 113-125. (Pubitemid 30419109)
34. Cottler LB, Campbell W, Krishna VAS, et al. Predictors of high rates of suicidal ideation among drug users. J Nerv Ment Dis. 2005;193: 431-437. (Pubitemid 40967746)
35. Dodge R, Sindelar J, Sinha R. The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment. J Subst Abuse Treat. 2005;28: 189-196. (Pubitemid 40380927)
36. ComptonWMIII, Cottler LB, Jacobs JL, et al. The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am J Psychiatry. 2003;160: 890-89
37. Cohen JB, Dickow A, Horner K, et al. Abuse and violence history of men and women in treatment for methamphetamine dependence. Am J Addict. 2003;12: 377-385. (Pubitemid 37449024)
38. Zimmerman M, Mattia JI. A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Arch Gen Psychiatry. 2001;58: 787-794. (Pubitemid 32717805)
39. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision [DSM-IV-TR]. 4th ed. Washington, DC: American Psychiatric Association; 2000.